18F-MFBG PET/CT in the Evaluation of Neural Crest Tumor
Recruiting now · Early Phase 1
Conditions studied: Neuroendocrine Tumor, Neuroblastoma, Pheochromocytoma, Paraganglioma
In brief
The aim of this study is to evaluate the diagnostic performance and tumor burden of 18F-metafluorobenzylguanidine (18F-MFBG) positron emission tomography (PET) in patients with neuroendocrine tumors mainly in pheochromocytoma and paraganglioma (PPGL) and neuroblastoma (NB).
Key facts
- Study ID
- NCT05069220
- Run by
- Peking Union Medical College Hospital
- People needed
- 150
- Starts
- 2021-09-01
- Expected to finish
- 2026-12-01
- Last updated by the study team
- 2024-03-01
Who can join
Age: 1 and older, up to 80. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- The subject has read, signed, and dated an informed consent form (ICF) prior to any study procedures being performed. Patients with histologically confirmed or clinically suspicious neural crest tumor.
- For patients with neuroblastoma, subject should have a routine clinical 123I-MIBG scintigraphy (planar + SPECT/CT) performed within 6 months prior to the inclusion visit or scheduled within 3 months after the inclusion visit.
- The subject is male or is a nonpregnant, nonlactating female who is either surgically sterile or is post-menopausal. The subject is able and willing to comply with all study procedures as described in the protocol.
You may not qualify if…
- Patients are potentially pregnant (serum and urinary hCG test will be performed in women where pregnancy is not excluded) or is breast-feeding.
- Patients undergo surgery between the selection and inclusion visit. Patients who are pregnant, may possibly be pregnant, or wish (including their partners) to become pregnant during the study period, or are lactating. Patients who are not suitable to participate in the trial according to researchers.
Where it is running
- Peking union medical college hospital — Beijing, Dongcheng, China (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.